ANTEGRIN THERAPEUTICS
Antegrin Therapeutics, LLC, is a drug discovery and development company focused on the development of novel therapies for fibrotic diseases. Our lead program aims to develop a treatment for idiopathic pulmonary fibrosis, a progressive, life-threatening condition that currently has no FDA-approved medication.
ANTEGRIN THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2012-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Total Employee:
1+
Status:
Closed
Contact:
(314)932-4032
Total Funding:
800 K USD
Technology used in webpage:
Domain Not Resolving Sitelinks Search Box Wordpress Plugins Gravity Forms Apache 2.2 Mod_ssl DAV OpenSSL 1.0.0 Dingfeng Xinhui DXTL Tseung Kawn
Founder
Investors List
BioGenerator
BioGenerator investment in Seed Round - Antegrin Therapeutics
Missouri Technology Corporation
Missouri Technology Corporation investment in Seed Round - Antegrin Therapeutics
iSelect Fund
iSelect Fund investment in Seed Round - Antegrin Therapeutics
BioGenerator
BioGenerator investment in Seed Round - Antegrin Therapeutics
More informations about "Antegrin Therapeutics"
Antegrin Therapeutics 2025 Company Profile: Valuation, Investors ...
Antegrin Therapeutics General Information Description. Developer of novel drugs intended to treat lung disease. The company develops compounds for the treatment of human fibrotic disease, …See details»
Indalo Therapeutics : Formed by Merger of Antegrin and Cascadia
Oct 17, 2016 Antegrin CEO George Capps, an accomplished business development professional and pharmaceutical executive, retains his post in the new organization. “The …See details»
Indalo Therapeutics Formed by Merger of Antegrin and Cascadia
Oct 17, 2016 The new organization unites Antegrin’s robust portfolio of small-molecule integrin antagonists with the strong drug-development expertise, seasoned executive experience, and …See details»
ANTEGRIN THERAPEUTICS, INC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ANTEGRIN THERAPEUTICS, INC of Saint Louis, MO. Get the latest business insights from Dun & …See details»
Antegrin Therapeutics - Products, Competitors, Financials, …
Antegrin Therapeutics is a pharmaceutical company dedicated to the development of novel therapies for fibrotic diseases, and offers a robust portfolio of small-molecule integrin …See details»
Antegrin Therapeutics - Overview, News & Similar companies
Antegrin Therapeutics, Inc., is a pharmaceutical company dedicated to developing novel treatments for fibrotic diseases. The company aims to select its first clinical development …See details»
Antegrin Therapeutics LLC - Company Profile and News
Company profile page for Antegrin Therapeutics LLC including stock price, company news, executives, board members, and contact informationSee details»
ANTEGRIN THERAPEUTICS, INC - govcb.com
ANTEGRIN THERAPEUTICS, INC (314) 882-6886, Fax:(314) 932-4038. 4320 Forest Park Ave, Suite 304 Saint Louis, MO 63108. Map & Directions. Company Profile Company Name: …See details»
Antegrin Therapeutics - Headquarter Location, Corporate Office …
Antegrin Therapeutics is Therapeutic Devices in United States that focus on life-threatening condition business. Founded in 2012. They cover business area such as developer, …See details»
What You Need to Know About Indalo Therapeutics
Dec 7, 2017 Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.The focus of the company is on the development of therapies to …See details»
Antegrin Therapeutics | IT History Society
Antegrin Therapeutics is a Biotechnology company located in 4320 Forest Park Ave., Ste. 304, St. Louis, MO, United States.Antegrin Therapeutics, LLC, is a drug discovery and development …See details»
Antegrin Therapeutics - Funding, Financials, Valuation & Investors
Antegrin Therapeutics is a Biotechnology company located in 4320 Forest Park Ave., Ste. 304, St. Louis, MO, United States. New. Resources. Advanced Search. ... How much funding has this …See details»
Indalo Therapeutics Formed by Merger of Antegrin and Cascadia
Oct 18, 2016 The new organization unites Antegrin’s robust portfolio of small-molecule integrin antagonists with the strong drug-development expertise, seasoned executive experience, and …See details»
Antegrin Therapeutics - Golden
Antegrin Therapeutics. A pharmaceutical company developing herapies for the treatment of fibrotic diseases. Overview Structured Data Issues Contributors Activity. Contents. …See details»
St.Louis University's First Spinout, Antegrin Therapeutics, Gets ...
Apr 14, 2013 BioGenerator, the local nonprofit venture development group, announced Tuesday it will invest in Antegrin Therapeutics, a startup company that develops compounds to treat …See details»
Antegrin to Develop Oral Integrin Antagonists to Treat PF and...
Apr 11, 2016 Antegrin Therapeutics recently announced that it is expanding its current medication portfolio to include anti-fibrosis agents that block proteins known as integrins.The …See details»
St.Louis University’s First Spinout, Antegrin Therapeutics, Gets ...
Apr 14, 2013 BioGenerator, the local nonprofit venture development group, announced Tuesday it will invest in Antegrin Therapeutics, a startup company that develops compounds to treat …See details»
Founder, Chief Executive Officer & President - Crunchbase
He currently serves as CSO of Tioma Therapeutics and previously served as President & CEO of Indalo (then. called Antegrin Therapeutics) from 2012-2015. Prior roles have included …See details»
BioGenerator Invests in Antegrin Therapeutics - BioSpace
LOUIS (April 2, 2013) — BioGenerator – the non-profit venture development organization of BioSTL – recently closed on an investment in Antegrin Therapeutics through its i6 Project …See details»
Peptide–Drug Conjugates as Next-Generation Therapeutics ... - MDPI
Apr 30, 2025 Peptide–drug conjugates (PDCs) have emerged as a next-generation therapeutic platform, combining the target specificity of peptides with the pharmacological potency of small …See details»